These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20662719)

  • 1. Mumps control today.
    Quinlisk MP
    J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comment on: Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D: Studies of the mumps epidemic in vaccinated children in Western Switzerland].
    Gasser-Bachmann M
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1970-1. PubMed ID: 9480538
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower long-term immunogenicity of mumps component after MMR vaccine.
    De Laval F; Haus R; Spiegel A; Simon F
    Pediatr Infect Dis J; 2010 Nov; 29(11):1062-3; author reply 1063. PubMed ID: 20975455
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
    Avijgan M; Habibian R; Kheiri S
    East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2001 serological survey in the Czech Republic--mumps.
    Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S50-3. PubMed ID: 15080260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mumps--occupational exposure and aspects of epidemiologic susceptibility].
    Hofmann F; Sydow B; Michaelis M
    Gesundheitswesen; 1994; 56(8-9):453-5. PubMed ID: 8000167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)].
    Mankertz A
    MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 11. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
    Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
    Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of mumps].
    Kaptsova TI
    Feldsher Akush; 1983; 48(4):7-10. PubMed ID: 6552997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy.
    Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
    Vaccine; 2011 Mar; 29(15):2785-90. PubMed ID: 21320550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saliva antibody testing and vaccination in a mumps outbreak.
    Ramsay ME; Brown DW; Eastcott HR; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R96-8. PubMed ID: 1669793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mumps vaccine virus transmission].
    Otrashevskaia EV; Kulak MV; Otrashevskaia AV; Karpov IA; Fisenko EG; Ignat'ev GM
    Vopr Virusol; 2013; 58(6):42-5. PubMed ID: 24772647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of previous mumps vaccination during a summer camp outbreak.
    Schaffzin JK; Pollock L; Schulte C; Henry K; Dayan G; Blog D; Smith P
    Pediatrics; 2007 Oct; 120(4):e862-8. PubMed ID: 17908742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characteristic of mumps virus from 2012 to 2016 and its serum antibody level among general healthy population during 2018-2020 in Jiangsu Province, China.
    Deng X; Hu Y; Lu P; Wang Z; Guo H
    BMC Infect Dis; 2024 Jul; 24(1):718. PubMed ID: 39039455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps vaccine effectiveness in highly immunized populations.
    Domínguez A; Torner N; Castilla J; Batalla J; Godoy P; Guevara M; Carnicer D; Caylà J; Rius C; Jansà JM
    Vaccine; 2010 Apr; 28(20):3567-70. PubMed ID: 20226249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.